American Oncology Network- Warrants (20/09/2028) EBIT

American Oncology Network- Warrants (20/09/2028) (AONCW) currently reports a EBIT of $-22M as of December 2024. That compares with $-42M in the prior-year period — up 46.4% year over year. That is above the sector sector average of $-69M. Use the charts on this page to explore American Oncology Network- Warrants (20/09/2028)'s EBIT history and peer comparisons.

American Oncology Network- Warrants (20/09/2028)'s EBIT increased from $-42M to $-22M — a 46.4% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

American Oncology Network- Warrants (20/09/2028)'s EBIT of $-22M is higher than the its sector sector average of $-69M. That is roughly 67.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

American Oncology Network- Warrants (20/09/2028) reported $-22M in EBIT as of December 2024. That compares with $-42M in the prior-year period — up 46.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-22M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-69M. From there, open related valuation or income-statement pages for American Oncology Network- Warrants (20/09/2028), and consider following AONCW for alerts when major investors trade the stock.